EllieMD review

What it is

EllieMD is a telehealth company whose website is owned by Ellie Health, Inc., with the EllieMD LLC name in its footer. Its founder and chief executive is Hanieh Sigari, who describes a background in geriatrics and longevity. It sells exclusively through independent brand partners, a direct-sales network whose members can earn compensation, and its testimonials note that some come from those partners. Beyond weight loss, it sells sermorelin, NAD⁺, glutathione, semax, selank, thymosin alpha-1, epitalon and other peptides, menopause hormone therapy, sexual-health products, skincare and a protein supplement. It says medication ships to all 50 states, though its FAQ says most states, and it doesn't serve U.S. territories. Disputes go to binding arbitration in Wilmington, Delaware.

How it works

You build a formula on the weight-loss page by choosing injection or oral drops, semaglutide or tirzepatide, and an additive, then complete a health assessment and pay. A state-licensed doctor or other qualified provider reviews it; depending on your state, that happens by secure messaging or a video visit, and a phone call may be required. If you're not eligible, the product payment is refunded. Medication ships from a licensed 503A compounding pharmacy, which its pages identify as CloveRx, and typically arrives within two to 15 business days. Each shipment is a vial meant to last 12 weeks. You then have provider messaging through the portal, a reassessment every three months and the option to switch product or tier at that point. Patients are also invited to weekly online education sessions and monthly in-person events, and can be matched with a brand partner. New first-tier patients receive a digital weight-management guide, a progress journal and a measuring tape with their first order. The FAQ explains storage too: refrigerate on arrival, though it says the medication is stable at room temperature for up to 56 days.

Pricing transparency

Every weight-loss plan runs at least three months and is charged up front. Injectable semaglutide with B12 is $239 a month on three months ($717 charged at once), $229 on six ($1,374) and $199 on twelve ($2,388). Injectable tirzepatide with B12 is $299 a month on three months ($897), $289 on six and $249 on twelve. Oral semaglutide drops are $299 a month on a three-month plan. A lower-dose microdose program runs $229 or $239 a month in 12-week blocks. The site promises no hidden membership, shipping or consultation fees. Plans renew automatically unless you cancel at least 48 hours before the renewal date, and its refund policy says the three-month minimum is owed in full even if you cancel partway or pay in installments. Canceling an order before it reaches a provider or pharmacy costs a $99 administrative fee, and nothing is refunded once the pharmacy processes it, even for side effects. Lab fees, if your provider asks for labs, are paid separately.

Branded vs compounded

EllieMD prescribes compounded semaglutide and compounded tirzepatide, which its pages call "GLP-1" and "GLP-1/GIP", compounded with B12, glycine or L-carnitine for weekly injection, or as twice-weekly oral drops using what it calls EllievaTec delivery. Oral drops are a less established route than injections, and their absorption isn't backed by published trials. The site discloses that compounded drugs aren't FDA-approved, but one FAQ answer describes "GLP-1 + B12" as FDA-approved for type 2 diabetes and weight management, which isn't true of a compounded product. Its eligibility rule accepts new patients with a BMI of 25 or higher, or 22 when transferring, below the FDA-labeled thresholds of 30, or 27 with a weight-related condition, which the same FAQ cites. A search of the FDA warning-letter database under EllieMD and Ellie Health returned no letters, and no LegitScript seal is shown.

Pros and watch-outs

The evidence behind what EllieMD prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Oral tirzepatide: the honest status of a pill that does not exist yet

  There is no FDA-approved oral tirzepatide. Here is why an oral peptide is hard, what the 'oral tirzepatide' sold online really is, and the oral incretins that actually exist.

• “Microdosing” GLP-1 drugs: a trend, not a protocol — what the evidence says

  Sub-therapeutic semaglutide and tirzepatide is spreading fast. The pharmacology is clear, the honest part is clearer: efficacy is dose-related, and no trial has tested intentional microdosing.

How EllieMD compares

A few alternatives worth a look, depending on what you’re optimizing for.

• MEMEDGm

  Readers who want compounded and brand-name GLP-1 routes presented side by side

  See MEDGm →
• Willow

  Buyers who want every dose priced and the pharmacies named, and will pay more for it

  See Willow →
• AlyveRx

  People who want to avoid needles and are willing to try a compounded sublingual GLP-1

  See AlyveRx →

More GLP-1 telehealth reviews: Direct Meds · Strut Health · CoreAge Rx · Oak Longevity · SnagRx · HumeCare+